Skip to main navigation Skip to search Skip to main content

New treatment for amblyopia based on rules of synaptic plasticity: a randomized clinical trial

  • Xin Huang
  • , Huika Xia
  • , Qi Zhang
  • , Colin Blakemore*
  • , Yan Nan
  • , Wenyao Wang
  • , Jie Gao
  • , Spencer S Ng
  • , Jing Wen
  • , Tiejun Huang*
  • , Xiaoqing Li*
  • , Mingliang Pu*
  • *Corresponding author for this work

Research output: Journal Publications and ReviewsRGC 21 - Publication in refereed journalpeer-review

Abstract

Amblyopia resulting from early deprivation of vision or defocus in one eye reflects an imbalance of input from the eyes to the visual cortex. We tested the hypothesis that asynchronous stimulation of the two eyes might induce synaptic plasticity and rebalance input. Experiments on normal adults showed that repetitive brief exposure of grating stimuli, with the onset of each stimulus delayed by 8.3 ms in one eye, results in a shift in perceptual eye dominance. Clinical studies (Clinical trial registration number: ChiCTR2100049130), using popular 3D movies with similar asynchrony between the two eyes (amblyopic eye stimulated first) to treat anisometropic amblyopia, established that just 10.5 h of conditioning over <3 weeks produced improvement that met criteria for successful treatment. The benefits of asynchronous conditioning accumulate over 20–30 45 min sessions, and are maintained for at least 2 years. Finally, we demonstrate that asynchronous binocular treatment alone is more effective than patching only. This novel treatment is popular with children and is some 50 times more efficient than patching alone.
Original languageEnglish
Pages (from-to)451-465
JournalScience China Life Sciences
Volume65
Issue number3
Online published6 Jan 2022
DOIs
Publication statusPublished - Mar 2022

Research Keywords

  • amblyopia
  • SED
  • STDP
  • synaptic plasticity
  • visual cortex

Fingerprint

Dive into the research topics of 'New treatment for amblyopia based on rules of synaptic plasticity: a randomized clinical trial'. Together they form a unique fingerprint.

Cite this